Orphanet: Networks
x

Search for a networks

* (*) mandatory field

A Trial Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone Deficiency

  • Type of network : Multinational clinical trials
  • Geographic coverage : Global
  • Funding body(ies) : NOVO NORDISK A/S 
  • Sponsor : Information not provided
  • Website
  • Coordinator of multinational clinical trial

  • INFORMATION NOT PROVIDED
  • Novo Nordisk A/S
  • Novo Alle
  • 2880 BAGSVAERD
  • DENMARK
  • More information
  • Phone  : 45 44 44 88 88
  • Fax  : 45 44 44 87 88
  • Website
Last update: January 2020

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.